A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria-Reference-Cited by-同舟云学术

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria

Published:2017-11-09 Issue:11 Volume:12 Page:e0187376
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fukuda Mark M.^ORCID,Krudsood Srivicha,Mohamed Khadeeja,Green Justin A.,Warrasak Sukhuma,Noedl Harald,Euswas Ataya,Ittiverakul Mali,Buathong Nillawan,Sriwichai Sabaithip,Miller R. Scott,Ohrt Colin

Funder

National Institute of Allergy and Infectious Diseases

GSK

US Army Medical Research and Material Command

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. World malaria report [Internet],2016

2. Adult and child malaria mortality in India: a nationally representative mortality survey;N Dhingra;Lancet,2010

3. Global epidemiology of Plasmodium vivax;RE Howes;Am J Trop Med Hyg,2016